New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Characterizing RNA alterations in cancer

Characterizing RNA alterations in cancer

by Vicky Hatch,European Molecular Biology LaboratoryArtists impression of a gene fusion network. Credit: Image courtesy of Nuno Fonseca, edited by Spencer Phillips.Researchers at EMBL-EBI were a
World medicine December 13,2023
Characterizing RNA alterations in cancer

Characterizing RNA alterations in cancer

by Vicky Hatch,European Molecular Biology LaboratoryArtists impression of a gene fusion network. Credit: Image courtesy of Nuno Fonseca, edited by Spencer Phillips.Researchers at EMBL-EBI were a
World medicine December 13,2023
AI does not improve advanced colorectal neoplasia detection rate

AI does not improve advanced colorectal neoplasia detection rate

by Elana GotkineComputer-aided detection (CADe) during colonoscopy to identify advanced colorectal neoplasias and adenomas and the benefits and harms of CADe were explored in both a randomized trial a
World medicine December 13,2023
AI does not improve advanced colorectal neoplasia detection rate

AI does not improve advanced colorectal neoplasia detection rate

by Elana GotkineComputer-aided detection (CADe) during colonoscopy to identify advanced colorectal neoplasias and adenomas and the benefits and harms of CADe were explored in both a randomized trial a
World medicine December 13,2023
A targeted therapy for triple negative breast cancer may lie existing drugs

A targeted therapy for triple negative breast cancer may lie existing drugs

byGraduate Center, CUNYThe illustrations show how coordination of the proteins mtp53 R273H, PARP, and MCM2-7 on replicating DNA likely play a role in tumor development for some breast cancers. I
World medicine December 13,2023
A targeted therapy for triple negative breast cancer may lie existing drugs

A targeted therapy for triple negative breast cancer may lie existing drugs

byGraduate Center, CUNYThe illustrations show how coordination of the proteins mtp53 R273H, PARP, and MCM2-7 on replicating DNA likely play a role in tumor development for some breast cancers. I
World medicine December 13,2023
Disparities seen in outcomes for young adults with CRC

Disparities seen in outcomes for young adults with CRC

(HealthDay)—Worse outcomes are seen for young adult (YA) patients with colorectal cancer (CRC) living in the lowest income and education areas, according to a study presented at the American Society o
World medicine December 13,2023
Disparities seen in outcomes for young adults with CRC

Disparities seen in outcomes for young adults with CRC

(HealthDay)—Worse outcomes are seen for young adult (YA) patients with colorectal cancer (CRC) living in the lowest income and education areas, according to a study presented at the American Society o
World medicine December 13,2023
How chromosome imbalances can drive cancer: An analysis of nearly 11,000 human cancers

How chromosome imbalances can drive cancer: An analysis of nearly 11,000 human cancers

by Sarah C.P. Williams,Broad Institute of MIT and HarvardCredit: Ricardo Job-Reese, Broad CommunicationsThe vast majority of cancer cells have too few or too many copies of some chromosomes, a s
World medicine December 13,2023
How chromosome imbalances can drive cancer: An analysis of nearly 11,000 human cancers

How chromosome imbalances can drive cancer: An analysis of nearly 11,000 human cancers

by Sarah C.P. Williams,Broad Institute of MIT and HarvardCredit: Ricardo Job-Reese, Broad CommunicationsThe vast majority of cancer cells have too few or too many copies of some chromosomes, a s
World medicine December 13,2023
TrackSig: Unlocking the history of cancer through tumor evolution

TrackSig: Unlocking the history of cancer through tumor evolution

by Hal Costie,University of TorontoDonnelly Centre and Ontario Institute for Cancer Research machine learning experts map the changes that lead to cancer, revealing opportunities for earlier dia
World medicine December 13,2023
TrackSig: Unlocking the history of cancer through tumor evolution

TrackSig: Unlocking the history of cancer through tumor evolution

by Hal Costie,University of TorontoDonnelly Centre and Ontario Institute for Cancer Research machine learning experts map the changes that lead to cancer, revealing opportunities for earlier dia
World medicine December 13,2023
Determining how a sugar molecule can affect cancer cell response to chemoradiotherapy

Determining how a sugar molecule can affect cancer cell response to chemoradiotherapy

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center and colleagues who have been exploring the
World medicine December 13,2023
Determining how a sugar molecule can affect cancer cell response to chemoradiotherapy

Determining how a sugar molecule can affect cancer cell response to chemoradiotherapy

byGeorgetown University Medical CenterCredit: Unsplash/CC0 Public DomainResearchers at Georgetown University's Lombardi Comprehensive Cancer Center and colleagues who have been exploring the
World medicine December 13,2023
Study uncovers unexpected connection between gliomas, neurodegenerative diseases

Study uncovers unexpected connection between gliomas, neurodegenerative diseases

by Haley Otman,University of MichiganCredit: CC0 Public DomainA protein typically associated with neurodegenerative diseases like Alzheimer's might help scientists explore how gliomas, a typ
World medicine December 13,2023
Study uncovers unexpected connection between gliomas, neurodegenerative diseases

Study uncovers unexpected connection between gliomas, neurodegenerative diseases

by Haley Otman,University of MichiganCredit: CC0 Public DomainA protein typically associated with neurodegenerative diseases like Alzheimer's might help scientists explore how gliomas, a typ
World medicine December 13,2023
Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

byMass General BrighamCredit: Unsplash/CC0 Public DomainEsophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20%. Although a precursor lesion to
World medicine December 13,2023
Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

Identification of genetic drivers for esophageal cancer creates new opportunity for screening, treatment

byMass General BrighamCredit: Unsplash/CC0 Public DomainEsophageal adenocarcinoma (EAC) is a highly lethal cancer, with a five-year survival rate of less than 20%. Although a precursor lesion to
World medicine December 13,2023
AI-based marker for colon cancer can help improve quality of treatment

AI-based marker for colon cancer can help improve quality of treatment

by Oslo University HospitalCredit: Institute for Cancer Genetics and Informatics, Oslo University HospitalA Norwegian-led research group has developed a clinically useful prognostic marker using deep
World medicine December 13,2023
AI-based marker for colon cancer can help improve quality of treatment

AI-based marker for colon cancer can help improve quality of treatment

by Oslo University HospitalCredit: Institute for Cancer Genetics and Informatics, Oslo University HospitalA Norwegian-led research group has developed a clinically useful prognostic marker using deep
World medicine December 13,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com